Antimony Potassium Tartrate
Active ingredient
Sold as apo-PULM · COUGHTONE · VACC HC · ANTIM TART
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 4
- FDA reports (12 mo)
- 45
Overview
Plain-language summary, compiled from the cited regulatory records
Antimony Potassium Tartrate is an active pharmaceutical ingredient. Its drug class is not specified in the provided information [1]. It is approved for indications listed or as directed by a physician [1].
This ingredient is available under various brand names, including apo-PULM, COUGHTONE, and VACC HC [1]. In the past 12 months, there have been 45 adverse event reports associated with this ingredient [2]. The most frequently reported adverse reactions include eye pain, diarrhea, fatigue, nausea, and decreased weight [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 4 | January 5, 2026 |
USUnited States· FDA
4 products
Uses
INDICATIONS
Condition listed above or as directed by the physician
How to take
Sources & citations
- [1]FDA DailyMed · 19a5e8ed-2063-9f… · revised May 30, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.